Zacks Investment Research on MSN
Inogen (INGN) up 6.8% since last earnings report: Can it continue?
A month has gone by since the last earnings report for Inogen (INGN). Shares have added about 6.8% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the recent ...
Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid fourth-quarter 2024 ...
Inogen has continued to struggle, with growth in the rental business overshadowed by declines in direct-to-consumer sales, volatility in business-to-business sales, and pricing pressures. Inogen has ...
Income tax impact of adjustments represents the tax impact related to the non-GAAP adjustments listed above and reflects an effective tax rate of 0% for 2025 and 2024.
(1) Income tax impact of adjustments represents the tax impact related to the non-GAAP adjustments listed above and reflects an effective tax rate of 0% for 2025 and 2024. The articles, information, ...
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced preliminary, unaudited revenue results for the ...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Compensation Committe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results